Trials / Completed
CompletedNCT03086408
Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) and Diagnostic Bronchoscopy
The Safety and Efficacy of the Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) for Short Diagnostic Bronchoscopy Procedures
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate whether diagnostic bronchoscopy can be safely and potentially more effectively performed without the use of tracheal intubation or a supraglottic airway, under completely unobstructed surgical conditions afforded by THRIVE: Transnasal Humidified Rapid- Insufflation Ventilatory Exchange. THRIVE provides patient's gas exchange through rapid insufflation of high-flow oxygen via specialized nasal cannula.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | THRIVE | active nasal oxygen delivery system |
| DEVICE | Endotracheal tube or Supraglottic airway | Plastic devices for mechanical ventilation |
Timeline
- Start date
- 2017-05-09
- Primary completion
- 2019-06-10
- Completion
- 2019-06-10
- First posted
- 2017-03-22
- Last updated
- 2020-07-17
- Results posted
- 2020-06-23
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03086408. Inclusion in this directory is not an endorsement.